[Hemostatic changes in extracorporeal surgery: pathogenesis and treatment].
Páramo
J A
JA
Servicio de Hematología, Facultad de Medicina, Universidad de Navarra, Pamplona.
Rifón
J
J
Rocha
E
E
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D016063:Blood Loss, Surgical; D001803:Blood Transfusion; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D003131:Combined Modality Therapy; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000209:etiology; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D005342:Fibrinolysis; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D006487:Hemostasis; D006801:Humans; D013921:Thrombocytopenia / Q000097:blood / Q000209:etiology; D013927:Thrombosis / Q000209:etiology
D000933:Antifibrinolytic Agents; D003894:Deamino Arginine Vasopressin
Alteraciones de la hemostasia en cirugía extracorpórea: patogénesis y tratamiento.